SAFE Is Back In Play

Have we paused the Rally?

Author

William McNarland
April 11, 2024

GM Everyone,

With one headline yesterday, we all caught a glimmer of hope once again as we heard that SAFE could potentially be inserted into a stablecoin bill that is heading to the floor for a vote. Upon hearing this, we weren't sure whether this is a net positive or negative, as we have seen some proponents in favor of cannabis be against crypto, so this could change some members' trajectory in terms of voting. On the other hand, this stablecoin bill is much needed and pretty cut and dry, which gives it an above-average chance of passing. So maybe this time it's different?! We will be watching closely as things progress and can't wait to give you the download from DC over the last week on Sunday at 8 pm ET. See you all there.

Today’s letter can be read in 6 minutes and 35 seconds. 

  • Johns Hopkins is starting to dive into the plant

  • Michigan is beggining to shine like the market it was supposed to

  • BTC is taking over Asia

  • All of Florida needs to vote #Yeson3

Capital Markets this Morning:

The futures are down, here is what is in focus globally for stocks:

  • March CPI miss fuels doubts of U.S. interest rate cut before November election, with futures markets adjusting expectations.

  • Stubborn rent rises, insurance costs, and 'core' CPI maintain annual core inflation at 3.8%, affecting Fed rate cut predictions.

  • Wall St and Treasury yields react sharply to CPI news; U.S. dollar jumps, highlighting global financial market tensions.

  • China's consumer inflation cools to 0.1%, indicating continued economic pressure and potential for more stimulus.

  • Middle East tensions and oil price hikes add to market concerns, with geopolitical developments influencing market sentiment.

Cannabis Capital Markets: John Hopkins Study shows D-Limonene Decreases Anxiety in THC Users

The TDR Takeaway: We mentioned this last month, but there is more news again about D-limonene from John Hopkins. High doses of d-limonene show promise in reducing THC-induced anxiety without impacting its beneficial effects. This study on d-limonene and THC opens new pathways for research, aiming at safer cannabis-based . Read all about in this article!

Cannabis Regulation: Michigan and Missouri Lead in Cannabis Industry Employment Surge

The TDR Takeaway: Cannabis legalization leads to job growth and tax revenue. Need further proof? Here are the results of a recent study. For more details, visit the TDR website.  For more details, visit the TDR website. 

Psychedelics: Silo Pharma Advances Alzheimer’s Disease Treatment with SPC-14

The TDR Takeaway: Psychedelics a cure for Alzheimers?  The SPC-14 therapeutic targets key neurological pathways, marking a crucial development in Alzheimer’s disease research and care. For more information, read about it on the TDR website.

Crypto: Bitcoin ETFs in Hong Kong: A New Era for Chinese Investors

The TDR Takeaway: Bitcoin ETFs in the USA were game changers, leading to a significant increase in price. With the introduction of ETFs in other countries, what will the effect be on the spot price? For more information, read about it on the TDR website. For more information, read about it on the TDR website.

AI News: Intel's Gaudi 3 Chip: A New Era in AI Semiconductor Industry

The TDR Takeaway! Everyday there is stories about Nvidia in most media sites. Could Intel take over? Read all about it on the TDR Website!

In this weeks episode of the Trade To Black podcast, we interview Kim Rivers, CEO of Trulieve. We will discuss the latest developments from Q1, including the Florida Supreme Court's approval of the initiative to include cannabis on the ballot this fall. We'll examine how this decision aligns with the company's growth and explore the potential need for further expansion in Florida.

Last Wednesday’s TDR's Trade To Black podcast features an interview with Rep. Nancy Mace. Our discussion focused on the current wait for cannabis rescheduling, the potential impact of a Trump presidency on the cannabis industry, and the level of access politicians have to the DEA. Get the insights straight from Washington, D.C.